Does VA Cover Wegovy? 2026 Coverage Criteria, Copays, and How to Apply
By The RX Index Editorial Team — a pricing intelligence and comparison resource for GLP-1 telehealth providers.
Published: · Last reviewed:
Reviewed quarterly or when VA, CHAMPVA, TRICARE, or Novo Nordisk policies change.
Some links on this page are affiliate links. We may earn a commission if you choose a featured provider, at no extra cost to you. Our coverage facts come from the VA Pharmacy Benefits Management Criteria for Use for Semaglutide (Wegovy, August 2025), 38 CFR §17.110, VA.gov 2026 copay rates, the CHAMPVA GLP-1 policy page, and TRICARE.mil. We do not change our recommendations based on payouts.
The short answer
Yes — VA can cover Wegovy, but only through a non-formulary, prior-authorization pathway, and only if you meet VA criteria. Wegovy is not on the VA National Formulary. Your VA prescriber must submit a non-formulary request showing you meet the VA's August 2025 Criteria for Use: documented participation in a comprehensive lifestyle program (MOVE! is the most common) plus a BMI of 30 or higher with at least one weight-related condition, unless a separate cardiovascular indication applies. Priority Group 1 veterans pay $0. Priority Groups 2–8 may pay the Tier 3 brand-name copay of $11 per 30-day supply unless an exemption applies.
Two important caveats upfront: CHAMPVA does not cover GLP-1 medications for weight loss. TRICARE is a separate Defense Department program with its own Wegovy rules. And the NovoCare $25 savings card? Federal-program beneficiaries — including VA, DOD, TRICARE, Medicare, and Medicaid — are excluded by the program's own terms.
This guide covers the full pathway: who qualifies, what to say at your appointment, what it actually costs, what to do if you get denied, and the savings-card trap every other page forgets to mention.
What we verified for this guide
- ✓VA Pharmacy Benefits Management Criteria for Use for Semaglutide (Wegovy), revised August 2025 — the official document your VA pharmacist uses
- ✓38 CFR Part 17 §17.110 — the federal regulation setting VA medication copay tiers
- ✓VA.gov 2026 copay rates for Tier 1, Tier 2, and Tier 3 brand-name drugs
- ✓VA.gov CHAMPVA Meds by Mail bulletin confirming GLP-1 coverage limits for dependents
- ✓TRICARE pharmacy FAQ for Wegovy, Ozempic, and Mounjaro coverage rules
- ✓NovoCare Savings Offer terms — including the exclusion language covering federal program beneficiaries
- ✓VA Formulary Advisor status for semaglutide and tirzepatide injections
- ✓NovoCare Pharmacy Direct pricing for Wegovy pen, Wegovy HD pen, and Wegovy pill
- ✓Two VA-conducted studies on semaglutide and GLP-1 outcomes in veterans
Where we could not pin a claim to a primary source, we flag it [needs local verification]. Don't act on those without calling your VA pharmacy first.
Your VA Wegovy pathway in one table
Find your row, see your path.
| Your situation | Wegovy covered? | What it takes | What you may pay |
|---|---|---|---|
| Enrolled veteran, Priority Group 1, BMI ≥30 + comorbidity, in MOVE! | Yes, via non-formulary request | CFU criteria + PA approval | $0/month for medications |
| Enrolled veteran, Priority Groups 2–8, BMI ≥30 + comorbidity, in MOVE! | Yes, via non-formulary request | CFU criteria + PA approval | $11 per 30-day supply (Tier 3); $700 annual cap; exemptions may apply |
| Enrolled veteran, BMI 27–29.9 + weight-related condition | Generally not under Wegovy CFU | Wegovy CFU requires BMI ≥30; ask provider which rule applies | Same tier rates if approved under a different pathway |
| Enrolled veteran, overweight/obesity + prior MI, stroke, or symptomatic PAD | Possible (cardiovascular indication) | Cardiovascular event history documented + CFU criteria | Same tier rates if approved |
| CHAMPVA beneficiary (spouse, dependent, survivor), weight loss only | No | — | Cash-pay; verify discount eligibility first |
| CHAMPVA beneficiary, MASH or MACE diagnosis | Generally yes | FDA-approved indication; verify with CHAMPVA/OptumRx | 25% allowable cost-share + $50 deductible |
| TRICARE Prime / Select / Reserve / Young Adult / USFHP / CHCBP | Yes — with PA | Network prescriber + comprehensive treatment plan + prior authorization | Standard TRICARE pharmacy copay |
| TRICARE For Life | No (weight loss) | — | Cash-pay; verify discount eligibility first |
| Veteran not VA-enrolled, or denied | Cash-pay or non-VA insurance only | Prescription from any licensed US prescriber | Brand-name Wegovy cash pricing varies — see discount-program traps below |
Not sure which row is yours?
Our free 60-second GLP-1 matching quiz will tell you the exact pathway, what to bring to your appointment, and what to do if you've already been denied.
Take the Free 60-Second GLP-1 Match Quiz →Does VA cover Wegovy for weight loss? The criteria decoded
The VA's August 2025 Criteria for Use requires: (1) active documented participation in a comprehensive lifestyle intervention covering diet, physical activity, and behavior change, and (2) a BMI of 30 or higher with at least one weight-related comorbidity. Wegovy is also recognized for reducing secondary cardiovascular-event risk in people with overweight or obesity and a history of MI, stroke, or symptomatic PAD. Exclusion and specialist-review criteria can still stop or delay approval.
Inclusion criteria — what you need to qualify
1. Documented Comprehensive Lifestyle Intervention (CLI)
This is the part most veterans skip. VA won't approve Wegovy just because you say you've been "trying to lose weight." It wants documented participation in a structured program covering diet, physical activity, and behavior change. The fastest way to satisfy this is the MOVE! Weight Management Program — free, available at every VA medical center, and you can self-refer. Group sessions, dietitian-led education, behavior change tools, and TeleMOVE! video sessions all count.
2. BMI of 30 or higher, plus at least one weight-related condition
Examples the VA recognizes:
- High blood pressure (hypertension)
- Type 2 diabetes
- High cholesterol (dyslipidemia)
- Metabolic syndrome
- Obstructive sleep apnea
- Osteoarthritis
- Metabolic dysfunction-associated steatotic liver disease (MASLD)
3. The cardiovascular indication
The VA CFU also recognizes Wegovy "to reduce a secondary cardiovascular event in people with previous myocardial infarction, previous stroke, or symptomatic peripheral arterial disease" in people with overweight or obesity. If you have one of those events on your chart, ask your VA clinician whether your request is being reviewed under chronic weight management criteria or the cardiovascular-risk indication — they are separate pathways.
Exclusion and specialist-review criteria — what can stop or delay approval
| Item | What it means in practice |
|---|---|
| Known pregnancy | Wegovy is not used during pregnancy |
| Lactating | Generally excluded from chronic weight-management criteria |
| Type 1 diabetes | Generally excluded, but semaglutide can be considered under specialist supervision in a diabetes/weight-management clinic |
| Personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 | Black-box warning; not used |
| Severe GI dysmotility (including gastroparesis) | Wegovy slows gastric emptying; generally not used |
| History of pancreatitis | Generally excluded — exception when the cause is known and no longer presents risk |
| Diabetic retinopathy concerns | Requires documented risk/benefit discussion and monitoring plan with an eye specialist |
What "weight-related comorbidity" actually means at your appointment
Your VA provider needs the comorbidity documented in your chart, not just mentioned in conversation. Before your appointment, gather your most recent labs, blood pressure readings, sleep study results (if you have one), and any imaging that supports a weight-related diagnosis. If your file doesn't reflect a condition you have, fix that before the non-formulary request goes in — the pharmacist reviewing it is looking at the EHR, not your verbal history.
Is Wegovy on the VA formulary?
No. Wegovy is "non-formulary with Criteria for Use" at the VA — not a standard pharmacy fill, but it can still be covered when a VA prescriber submits a non-formulary request and the medication meets the VA's published criteria. The VA Pharmacy Benefits Management team typically reviews these within 96 hours.
A formulary drug is one VA stocks and dispenses routinely. A non-formulary drug like Wegovy still gets prescribed and filled — but only after a clinical pharmacist reviews the request against the Criteria for Use. A non-formulary denial is not a permanent "no" — the denial letter tells you what's missing, and your prescriber can resubmit.
Mounjaro vs. Ozempic vs. Wegovy vs. Zepbound at the VA
| Medication | VA Formulary status | FDA indication | What VA covers it for |
|---|---|---|---|
| Ozempic (semaglutide injection) | Formulary with prior authorization | Type 2 diabetes | Type 2 diabetes only |
| Mounjaro (tirzepatide injection) | Non-formulary with PA required | Type 2 diabetes | Diabetes-indicated pathway only |
| Wegovy (semaglutide weight-management injection) | Non-formulary with Criteria for Use | Chronic weight management; CV risk reduction | Weight management + CV indication |
| Zepbound (tirzepatide weight-management injection) | Non-formulary with Criteria for Use | Chronic weight management; sleep apnea | Weight management pathway |
Wegovy and Ozempic share semaglutide as their active molecule, but VA treats them as completely different coverage requests. You cannot substitute one for the other to game coverage — the dose, indication, and labeling are different. Ask specifically for Wegovy for weight management.
How much you may pay for Wegovy through VA
If VA approves your non-formulary Wegovy request and classifies the fill as a Tier 3 brand-name outpatient medication, Priority Group 1 veterans pay $0 and Priority Groups 2–8 may pay $11 per 30-day supply, $22 per 60-day supply, or $33 per 90-day supply — capped at $700 per calendar year across all VA prescriptions, with exemptions available.
2026 copay schedule from VA.gov and 38 CFR §17.110:
| Priority Group | 30-day supply | 60-day supply | 90-day supply | Annual cap |
|---|---|---|---|---|
| Group 1 (50%+ service-connected, unemployable, Medal of Honor) | $0 | $0 | $0 | N/A |
| Groups 2–6 (service-connected and non-service-connected) | $11* | $22* | $33* | $700 |
| Groups 7–8 (above income thresholds, copay agreement) | $11* | $22* | $33* | $700 |
*Subject to VA copay exemptions based on disability rating, income level, special eligibility factors, and whether the prescription is treated as related to a service-connected condition.
The $700 annual cap is real. It covers your total VA prescription copays for the year, not just Wegovy. If you take other medications, you may hit the cap mid-year and pay nothing for the rest of the calendar year.
For context: Wegovy's list price is about $1,349 per month, and NovoCare Pharmacy's flat cash price is $349 per month. The VA pathway, when it works, is dramatically cheaper than every other route.
Step-by-step: how to get Wegovy through VA
The fastest realistic pathway: (1) book a VA primary care appointment specifically framed around weight management, (2) enroll in MOVE! or document equivalent comprehensive lifestyle intervention, (3) ask your PCP to submit a non-formulary Wegovy request with prior authorization, and (4) wait roughly 96 hours for the pharmacy benefits review.
Book the appointment with the right framing
Don't book a generic "wellness visit" and try to bring Wegovy up at the end. Schedule the appointment and tell the scheduler the visit is about weight management. That framing gets you a longer slot and a provider who's ready for the conversation.
Enroll in MOVE! (you can do this the same week)
You can self-refer to MOVE! at most VA facilities. Call your facility's MOVE! coordinator or message through My HealtheVet. Enroll in MOVE! and request Wegovy at the same time — the two are complementary, not sequential. VA research on 201 veterans at the Rocky Mountain Regional VA Medical Center found that veterans prescribed semaglutide combined with MOVE!-style support averaged 10% body weight loss after one year, with improvements in BMI, blood pressure, LDL cholesterol, triglycerides, and blood sugar.
At your appointment, use this language
Copy this and bring it. It maps directly to the VA Criteria for Use:
"I'd like to be evaluated for VA weight-management medication, specifically Wegovy if it's clinically appropriate. My current BMI is ____. I have documented weight-related conditions including ____. I'm enrolled in (or being referred to) MOVE! and I'm participating in the lifestyle intervention requirements. I'd like you to consider submitting a non-formulary Wegovy request with prior authorization."
If your provider is unsure — which happens — ask for a referral to endocrinology or your facility's weight management clinic. Those specialists handle Wegovy requests routinely.
The 96-hour pharmacy review
Once your prescriber submits the non-formulary request, the VA Pharmacy Benefits Management team typically reviews within 96 hours. If denied, the denial letter tells you exactly what's missing — that's the document you need for the next step.
Filling the prescription
Approved Wegovy prescriptions are typically mailed through the VA pharmacy mail-order process rather than picked up at the outpatient pharmacy, depending on local facility policy. Plan ahead by 7–14 days for refills. (Note: "Meds by Mail" is the separate CHAMPVA mail-order program for dependents, not the enrolled-veteran process.)
Does CHAMPVA cover Wegovy?
No — CHAMPVA does not cover GLP-1 medications for weight loss. CHAMPVA's GLP-1 policy box says Wegovy is covered for MASH or MACE diagnoses only. The alphabetical Wegovy entry on the same page currently lists only MACE — so before relying on CHAMPVA coverage for MASH, call CHAMPVA/OptumRx with your exact diagnosis code.
This trips up veteran families because CHAMPVA sounds like VA, but it's a different program with different rules.
| Program | Who it covers |
|---|---|
| VA health care | Enrolled veterans |
| CHAMPVA | Spouses, dependent children, and surviving family members of veterans who meet specific service-connected disability requirements |
| Diagnosis | CHAMPVA Wegovy coverage |
|---|---|
| Weight loss only | Not covered |
| MACE (prior heart attack, stroke, or PAD prevention) | Listed as covered |
| MASH | Listed in policy box — verify with CHAMPVA/OptumRx using your exact diagnosis code |
| Type 2 diabetes (Wegovy is not FDA-approved for T2D) | Not the right drug — Ozempic, Mounjaro, Rybelsus, Trulicity, or Victoza for T2D |
| Obstructive sleep apnea | Zepbound is the covered option, not Wegovy |
CHAMPVA covers eligible medications through OptumRx network pharmacies or the Meds by Mail program, with a $50 individual / $100 family annual deductible and a 25% allowable cost-share after that. The household out-of-pocket cap is $3,000 per year.
Does TRICARE cover Wegovy?
TRICARE is a Defense Department program, separate from VA. TRICARE covers Wegovy for certain beneficiaries on TRICARE Prime, TRICARE Select, Reserve, Young Adult, Retired Reserve, US Family Health Plan, and CHCBP — with clinical criteria, a network-provider prescription, and prior authorization. TRICARE For Life does not cover weight-loss GLP-1s since August 31, 2025.
| Program | Who qualifies |
|---|---|
| VA health care | Enrolled veterans |
| CHAMPVA | Dependents/survivors of qualifying disabled veterans (not eligible for TRICARE) |
| TRICARE Prime, Select, Reserve Select, premium plans | Active-duty service members, retirees under 65, and their families |
| TRICARE For Life | Medicare-eligible military retirees, mostly age 65+ |
For the complete TRICARE Wegovy coverage breakdown — plan-by-plan matrix, the 6 PA denial gates, copays ($0–$85), and what TFL beneficiaries can do — see our full guide:
TRICARE Wegovy Coverage: Full 2026 Guide →Can veterans use the NovoCare $25 savings card or self-pay offer?
Usually no. NovoCare's published Wegovy offer terms exclude patients enrolled in any federal or state health care program — including VA, DOD, TRICARE, Medicare, and Medicaid — even when trying to process as self-pay through the savings program. This is the single biggest blind spot on every other "does VA cover Wegovy" article.
The $25 savings card is closed to federal beneficiaries
The $25 Wegovy Savings Card sounds great — but the official terms explicitly exclude patients enrolled in any federal or state health care program. This is federal anti-kickback law. You cannot stack the savings card with VA benefits, and you cannot use the card even outside VA if you're a federal beneficiary.
The $199 new-patient intro offer has the same exclusion
NovoCare currently runs a limited-time intro offer of $199/month for the first 2 fills on the lowest doses (0.25 mg and 0.5 mg), running through June 30, 2026. The Wegovy Savings Offer terms that govern this intro pricing carry the same federal-program exclusion. Do not assume you can access the $199 intro pricing without verifying eligibility first.
What about the $349 NovoCare Pharmacy Direct flat self-pay rate?
| Formulation | NovoCare Pharmacy Direct flat price | Federal-beneficiary eligibility |
|---|---|---|
| Wegovy injection (0.25 mg–2.4 mg) | $349/month | Verify with NovoCare before relying on this price |
| Wegovy HD (7.2 mg) | $399/month | Verify with NovoCare before relying on this price |
| Wegovy tablet (1.5 mg, 4 mg) | $149/month (4 mg offer through Aug 31, 2026, then $199) | Verify with NovoCare before relying on this price |
| Wegovy tablet (9 mg, 25 mg) | $299/month | Verify with NovoCare before relying on this price |
Call NovoCare directly before relying on any quoted price as a VA, DOD, TRICARE, Medicare, or Medicaid beneficiary. NovoCare's offer terms include broad exclusions covering federal programs even for patients trying to use self-pay routes.
What to do if your VA Wegovy request is denied
A denial isn't the end. The denial letter must state the reason and the documentation needed for a future request. You have three real paths: (1) fix the missing documentation and resubmit, (2) appeal through your VA care team or Patient Advocate, or (3) get a referral to endocrinology or weight management specialty.
Five most common denial reasons and what to ask next:
| Denial reason | What to ask next |
|---|---|
| No comprehensive lifestyle intervention documented | "What CLI participation do you need documented before reconsideration? Will MOVE! enrollment alone satisfy this?" |
| BMI or comorbidity not in the EHR | "Can we document my BMI and weight-related conditions in my chart today, then resubmit?" |
| Formulary-first or local scarcity rule | "Is there a formulary alternative I need to try first? What is the current local new-start threshold here?" |
| Clinical contraindication concern | "What specific medical concern is blocking approval, and is a specialist referral appropriate?" |
| Wrong medication or indication pathway | "Is this being reviewed under chronic weight management, the cardiovascular-risk indication, or another pathway?" |
If VA is delayed, locally restricted, or denied
Ro Body offers a free GLP-1 insurance coverage checker — their specialists contact your insurance to prepare a personalized coverage report, including whether prior authorization is required. For veterans with non-VA commercial coverage who want clinical support, Ro is the strongest fit for this query.
Check Non-VA GLP-1 Coverage with Ro — Free →Local VA restrictions and the MISSION Act
Local VA facilities can apply stricter rules than national policy. For example, VA San Diego has published guidance stating that — because of injectable GLP-1 shortages and resource scarcity — new starts at their facility were limited to patients with a BMI of 40 or higher. That is a local rule, not a national one. If you get denied for a reason that doesn't match the national CFU criteria, ask whether it's a local restriction and how to get on the list when it loosens.
The MISSION Act expanded veteran access to non-VA community providers, but it doesn't let you fill a routine Wegovy prescription at a non-VA retail pharmacy on VA's dime. VA urgent-care and community-care prescriptions can be filled at an in-network community pharmacy for up to a 14-day supply when the medication is eligible. Routine or maintenance prescriptions must be filled through VA for VA payment to apply.
If VA won't cover Wegovy: your non-VA FDA-approved options
If you've been denied, you're on CHAMPVA for weight loss, you're on TRICARE For Life, or you don't want to wait through the non-formulary process, these are the cleanest FDA-approved Wegovy paths — with the federal-beneficiary eligibility caveat noted for each.
Option 1: Ro Body — telehealth with insurance coverage support
For veterans who want clinical oversight, a transparent monthly price, and someone who can help with the insurance side if you have non-VA commercial coverage, Ro Body is the strongest fit. Ro carries FDA-approved Wegovy pen, Wegovy pill, Zepbound pen, Zepbound KwikPen, and Foundayo (orforglipron, FDA-approved April 1, 2026), plus a free GLP-1 Insurance Coverage Checker — Ro says its insurance specialists contact your insurance company to prepare a personalized coverage report, including whether prior authorization is required.
- ✓$39 for the first month, then $149/month ongoing
- ✓As low as $74/month with annual plan paid upfront
- ✓Medication cost is separate from membership (verify current pricing)
Honest tradeoff: Ro Body is membership-based — you're paying for clinical support and coverage-check services, not just the medication. If you only want the lowest sticker price on a Wegovy pen, NovoCare's self-pay channel can be lower on medication alone (eligibility permitting). If your non-VA insurance situation needs sorting or you want clinical wraparound, that time savings may be worth it.
Get Started with Ro Body — $39 First Month →Option 2: Sesame Care — self-pay marketplace with transparent pricing
Sesame Care is a self-pay marketplace with transparent per-visit pricing. It lists a broad menu of branded GLP-1 options including Wegovy, Zepbound, Ozempic, and Foundayo, with a Costco partnership for some medications. Best fit if you want to compare multiple branded GLP-1s on one platform, prefer single-visit pricing over a monthly membership, or are a Costco member.
Compare GLP-1 Options on Sesame Care →Option 3: NovoCare Pharmacy Direct — verify eligibility first
The manufacturer's flat self-pay channel — $349/month for standard Wegovy injections, $399 for Wegovy HD, $149–$299/month for Wegovy tablets. As covered above, federal-program beneficiaries should verify eligibility with NovoCare directly before relying on these prices. The savings program terms may exclude VA, DOD, TRICARE, Medicare, and Medicaid beneficiaries even on self-pay paths.
Other GLP-1 medications and VA — quick reference
VA covers Ozempic for type 2 diabetes (formulary, with prior authorization). Mounjaro is non-formulary. Zepbound follows the same non-formulary pathway as Wegovy. Orlistat, phentermine/topiramate (Qsymia), and bupropion/naltrexone (Contrave) are on the VA formulary as oral weight-management options.
| Medication | VA status | Indication |
|---|---|---|
| Ozempic (semaglutide) | Formulary with PA | Type 2 diabetes only |
| Mounjaro (tirzepatide) | Non-formulary with PA | Type 2 diabetes, non-formulary |
| Wegovy (semaglutide weight mgmt) | Non-formulary with CFU | Chronic weight management; CV risk reduction |
| Zepbound (tirzepatide weight mgmt) | Non-formulary with CFU | Chronic weight management; sleep apnea |
| Saxenda (liraglutide) | Non-formulary | Weight management |
| Foundayo (orforglipron) | Needs local verification | FDA-approved April 1, 2026 — ask your VA pharmacy |
| Orlistat, Qsymia, Contrave | Formulary | Oral weight-management options |
Some facilities may consider formulary oral options before approving non-formulary injectables, especially during shortages.
What VA-conducted research shows about semaglutide in veterans
Rocky Mountain Regional VA Medical Center (Aurora, CO)
Tracked 201 veterans prescribed semaglutide in the facility's weight management clinic. After one year, those veterans averaged 10% body weight loss and showed measurable improvements in BMI, blood pressure, LDL cholesterol, triglycerides, and blood sugar, plus self-reported quality-of-life improvements. Published in the Journal of General Internal Medicine.
VA St. Louis Healthcare System
Researchers studied more than 600,000 veterans with diabetes and found associations between GLP-1 medication use and lower recorded risks of several substance-use disorders and suicidal ideation. This was observational GLP-1 research in veterans with diabetes, not proof that Wegovy causes those outcomes for weight-loss patients.
These studies show GLP-1 medications can produce meaningful weight loss and cardiometabolic improvements in real-world VA populations when paired with structured lifestyle support. They do not prove any individual veteran will see the same results, or that VA will approve your specific request.
Mistakes that cause veterans to get the wrong answer
The most common reason veterans walk away thinking "VA doesn't cover Wegovy" is that the wrong question gets asked. Five mistakes we see most often:
Confusing VA health care with CHAMPVA
VA health care (for enrolled veterans) and CHAMPVA (for dependents and survivors) are different programs with different rules. A "yes" for a veteran does not mean a "yes" for a CHAMPVA spouse.
Asking for Ozempic when you want Wegovy
These are different coverage requests. Asking for "Ozempic for weight loss" gets you denied because Ozempic isn't FDA-approved for weight loss. Ask for Wegovy for weight management.
Skipping MOVE! or comprehensive lifestyle documentation
"I've been trying to diet" doesn't satisfy the CFU. VA needs documented participation in a structured program. MOVE! is the fastest path. Enroll, attend, document.
Assuming national policy equals local availability
Your local VA facility can layer stricter rules on top of national criteria — VA San Diego's BMI 40 scarcity threshold is one example. If denied for a reason that doesn't match national criteria, ask whether it's a local policy.
Sending a private prescription to a VA pharmacy expecting it to be filled
A non-VA prescription doesn't bypass VA's review process. The MISSION Act allows short-term (up to 14-day) fills for eligible urgent or community-care prescriptions; routine or maintenance supply needs to flow through VA.
Frequently asked questions about VA Wegovy coverage
Does VA pay for Wegovy?
▼
Yes, VA can cover Wegovy as a non-formulary medication with prior authorization, if you meet the August 2025 Criteria for Use: BMI of 30 or higher with at least one weight-related comorbidity (or overweight/obesity with prior MI, stroke, or symptomatic PAD), plus documented participation in a comprehensive lifestyle intervention. Wegovy is not on the VA National Formulary.
How do I get Wegovy through VA?
▼
Book a VA primary care appointment about weight management, enroll in MOVE! (or document equivalent comprehensive lifestyle intervention), and ask your VA prescriber to submit a non-formulary Wegovy request with prior authorization. The VA pharmacy benefits team typically reviews requests within 96 hours.
How much does Wegovy cost with VA coverage?
▼
If VA approves Wegovy and classifies the fill as a Tier 3 brand-name medication, Priority Group 1 veterans pay $0 and Priority Groups 2–8 may pay $11 per 30-day supply, $22 per 60-day supply, or $33 per 90-day supply — subject to copay exemptions and a $700 annual cap on total VA prescription copays.
Does CHAMPVA cover Wegovy?
▼
Not for weight loss. CHAMPVA's GLP-1 policy box says Wegovy is covered for MASH or MACE diagnoses. The alphabetical Wegovy entry on the same page currently lists only MACE. Verify with CHAMPVA/OptumRx using your exact diagnosis code before relying on coverage for MASH.
Does TRICARE cover Wegovy?
▼
TRICARE covers Wegovy for weight management for certain Prime, Select, Reserve, Young Adult, Retired Reserve, US Family Health Plan, and CHCBP beneficiaries who meet clinical criteria and prior-authorization rules. TRICARE For Life and certain other groups are excluded for weight-loss drugs since August 31, 2025.
Is Wegovy on the VA formulary?
▼
No. Wegovy is non-formulary with Criteria for Use at the VA, which means it requires a non-formulary drug request and prior authorization through your VA prescriber. The VA Formulary Advisor public listing reflects non-formulary status with prior approval required.
Why does VA cover Ozempic but not Wegovy on the formulary?
▼
Ozempic and Wegovy share semaglutide as their active ingredient, but VA covers based on FDA indication. Ozempic is FDA-approved for type 2 diabetes and is on the VA formulary with prior authorization. Wegovy is FDA-approved for chronic weight management and is non-formulary, requiring a separate non-formulary request under the VA's weight-management Criteria for Use.
Can I use the NovoCare $25 Savings Card if I'm a veteran?
▼
No. The NovoCare Savings Offer terms exclude patients enrolled in any federal or state health care program, including VA, DOD, TRICARE, Medicare, and Medicaid — even when trying to process as self-pay. The $199 new-patient intro offer (through June 30, 2026) has the same exclusion. For NovoCare Pharmacy Direct's flat-rate self-pay channel ($349/month for standard Wegovy doses), federal-program beneficiaries should verify eligibility with NovoCare before relying on any quoted price.
What happens if my VA Wegovy non-formulary request is denied?
▼
Your denial letter will state the specific reason. Ask your VA pharmacist what supporting information would support a resubmission, appeal through your VA care team, escalate to your facility's Patient Advocate, or request a referral to endocrinology or a weight-management clinic.
Will requesting Wegovy affect my VA disability rating?
▼
No. Requesting Wegovy from your VA clinician is a health-care request, not a disability-rating claim. Disability ratings are changed through VA benefits processes, not because you ask your clinician about a medication. If you're concerned about a specific claim, rating review, or reexamination, talk to a VA-accredited representative.
Can my private doctor prescribe Wegovy and have VA fill it?
▼
Possibly, but not automatically. VA still has to review the prescription against local criteria, and the VA prescriber or pharmacist makes the final fulfillment decision. The MISSION Act allows short-term (up to 14-day) non-VA pharmacy fills for eligible urgent or community-care prescriptions, but routine or maintenance supply generally needs to flow through a VA prescriber.
Does VA cover the Wegovy pill?
▼
The Wegovy pill (oral tablet) is FDA-approved, but the VA Criteria for Use document we verified is written specifically for the semaglutide subcutaneous injection for weight management. Whether the Wegovy pill follows the same non-formulary pathway at your specific VA facility needs local verification — ask your VA pharmacy directly.
What weight-loss medications are on the VA formulary?
▼
Orlistat (Xenical, Alli), phentermine/topiramate (Qsymia), and bupropion/naltrexone (Contrave) are listed in VA weight-management guidance as formulary options. Wegovy, Zepbound, and Saxenda are available by non-formulary request with Criteria for Use.
Related coverage guides
Does TRICARE Cover Wegovy?
Plan-by-plan breakdown, PA denial gates, and 2026 copays.
Does Humana Cover Wegovy?
Commercial, MAPD, Medicare Bridge, and PA checklist.
Does Cigna Cover Wegovy?
Cigna PA rules, step therapy, and alternatives.
Find My GLP-1 Path →
60-second quiz to find your best Wegovy access route.
Still not sure which path is yours?
Every veteran's situation is different — your priority group, BMI, comorbidities, branch of service, and whether you've already been denied all change the right next move.
Ro Body: $39 for the first month, then $149/month, or as low as $74/month with annual plan. Medication cost is separate. Verify current pricing at Ro. Affiliate link — we may earn a commission at no cost to you.
What we'll keep verifying
This page is updated quarterly at minimum, and more often when VA, FDA, TRICARE, or Novo Nordisk policy changes. We re-check: VA Wegovy Criteria for Use, VA Formulary Advisor status for semaglutide and tirzepatide, VA copay rates against 38 CFR §17.110, CHAMPVA GLP-1 coverage rules, TRICARE Wegovy coverage by plan group, NovoCare pricing and savings-card offer terms, and FDA enforcement updates on compounded GLP-1 products.
If you're reading this more than 90 days after the "Last verified" date at the top, call your VA pharmacy or the relevant program before acting on any specific dollar amount or policy detail.